Health
Medical
Pharmaceutical
OptiNose
$6.059876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.17%) As of 12:51 PM EDT today
-$0.01 (-0.17%) Today
Why Robinhood?
You can buy or sell OptiNose and other stocks, options, ETFs, and crypto commission-free!
About OPTN
OptiNose, Inc. Common Stock, also called OptiNose, is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Read More Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in May 2010 and is headquartered in Yardley, PA.
Employees
102
Headquarters
Yardley, Pennsylvania
Founded
2010
Market Cap
250.06M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
319.32K
High Today
$6.16
Low Today
$5.84
Open Price
$6.04
Volume
96.91K
52 Week High
$24.55
52 Week Low
$5.66
Collections
Health
Medical
Pharmaceutical
2017 IPO
US
North America
Price Paid on Robinhood
53% Lower
Right Now
52 Week Low
$5.66
Average Price Paid
$12.90
52 Week High
$24.55
OPTN Earnings
-$0.82
-$0.71
-$0.61
-$0.50
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 13, Pre-Market